Just as a clinician would not prescribe the same medication or dosage to every patient—even if they present with similar symptoms—brain-based therapies also benefit from a personalized approach. Traditional TMS protocols often apply a standardized treatment setting across patients, regardless of individual differences in brain activity, condition, or neurological patterns.

In general, healthy brainwave activity in the alpha range is often described as falling roughly between 8 and 12 hertz, though each person’s optimal frequency can vary. Conventional TMS approaches commonly target an average value within this range, often around 10 hertz, as a general benchmark.

PrTMS® takes a more individualized approach by using ongoing measurements to help guide treatment toward each patient’s own optimal brainwave frequency. The goal is to support more precise, personalized neuromodulation that reflects how each unique brain functions, rather than relying on a single standardized target for everyone.